162 related articles for article (PubMed ID: 38731207)
1. Osteonecrosis of the Jaw Associated with Bisphosphonates Infusion for Treatment of Plasma Cell Myeloma-A Retrospective Observational Study of Northern Portuguese Population.
Ferreira SS; Amaral JBD; Pacheco JJ; Salazar F; Monteiro L
J Clin Med; 2024 May; 13(9):. PubMed ID: 38731207
[No Abstract] [Full Text] [Related]
2. Interventions for managing medication-related osteonecrosis of the jaw.
Beth-Tasdogan NH; Mayer B; Hussein H; Zolk O
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012432. PubMed ID: 28983908
[TBL] [Abstract][Full Text] [Related]
3. Interventions for managing medication-related osteonecrosis of the jaw.
Beth-Tasdogan NH; Mayer B; Hussein H; Zolk O; Peter JU
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD012432. PubMed ID: 35866376
[TBL] [Abstract][Full Text] [Related]
4. Medication-related osteonecrosis of the jaw: a preliminary retrospective study of 130 patients with multiple myeloma.
Choi WS; Lee JI; Yoon HJ; Min CK; Lee SH
Maxillofac Plast Reconstr Surg; 2017 Dec; 39(1):1. PubMed ID: 28101496
[TBL] [Abstract][Full Text] [Related]
5. Maxilla osseus sequestre and oral exposure: effects of the treatment of multiple myeloma with bisphosphonates.
Lobato JV; Rodrigues JM; Cavaleiro MV; Lobato JM; Xavier L; Santos JD; Maurício AC
Acta Med Port; 2007; 20(2):185-92. PubMed ID: 17868526
[TBL] [Abstract][Full Text] [Related]
6. Medication-related osteonecrosis of the jaw (MRONJ) and eNOS Polymorphisms in multiple myeloma patients: a single center experience.
Taş Ozyurtseven B; Serin I; Nursal AF; Pehlivan S; Pehlivan M
BMC Oral Health; 2021 May; 21(1):272. PubMed ID: 34006261
[TBL] [Abstract][Full Text] [Related]
7. A real-world study on the prevalence and risk factors of medication related osteonecrosis of the jaw in cancer patients with bone metastases treated with Denosumab.
Bracchi P; Zecca E; Brunelli C; Miceli R; Tinè G; Maniezzo M; Lo Dico S; Caputo M; Shkodra M; Caraceni AT
Cancer Med; 2023 Sep; 12(17):18317-18326. PubMed ID: 37559413
[TBL] [Abstract][Full Text] [Related]
8. Multiple myeloma and chemical maxillary osteonecrosis. Can both occur simultaneously?
Junquera S; Álvarez-Yagüe E; Junquera L; Ugalde R; Rúa L
J Stomatol Oral Maxillofac Surg; 2020 Nov; 121(5):523-526. PubMed ID: 31863926
[TBL] [Abstract][Full Text] [Related]
9. A population based study of multiple myeloma patients with medication-related osteonecrosis of the jaw.
Auzina D; Slaidina A; Sevastjanova M; Erts R; Lejnieks A; Lejniece S
Stomatologija; 2019; 21(1):13-17. PubMed ID: 31619658
[TBL] [Abstract][Full Text] [Related]
10. Medication-related osteonecrosis of the jaw after tooth extraction in patients receiving pharmaceutical treatment for osteoporosis: A retrospective cohort study.
Seki K; Kaneko T; Kamimoto A; Wada M; Takeuchi Y; Furuchi M; Iinuma T
J Dent Sci; 2022 Oct; 17(4):1619-1625. PubMed ID: 36299343
[TBL] [Abstract][Full Text] [Related]
11. The effect of drug holiday before tooth extraction on the development of medication-related osteonecrosis of the jaw in cancer patients receiving intravenous bisphosphonates.
Karaca Ç; Topaloğlu-Yasan G; Adiloğlu S; Usman E
J Korean Assoc Oral Maxillofac Surg; 2023 Apr; 49(2):68-74. PubMed ID: 37114444
[TBL] [Abstract][Full Text] [Related]
12. Medication-Related Osteonecrosis of the Jaw Around Dental Implants: Implant Surgery-Triggered or Implant Presence-Triggered Osteonecrosis?
Giovannacci I; Meleti M; Manfredi M; Mortellaro C; Greco Lucchina A; Bonanini M; Vescovi P
J Craniofac Surg; 2016 May; 27(3):697-701. PubMed ID: 27092912
[TBL] [Abstract][Full Text] [Related]
13. Incidence and risk factors associated to Medication-Related Osteo Necrosis of the Jaw (MRONJ) in patients with osteoporosis after tooth extractions. A 12-months observational cohort study.
Cuozzo A; Iorio-Siciliano V; Vaia E; Mauriello L; Blasi A; Ramaglia L
J Stomatol Oral Maxillofac Surg; 2022 Nov; 123(6):616-621. PubMed ID: 35609780
[TBL] [Abstract][Full Text] [Related]
14. The effect of drug holiday on preventing medication-related osteonecrosis of the jaw in osteoporotic rat model.
Zhu WY; Yang WF; Wang L; Lan X; Tao ZY; Guo J; Xu J; Qin L; Su YX
J Orthop Translat; 2023 Mar; 39():55-62. PubMed ID: 36721766
[TBL] [Abstract][Full Text] [Related]
15. Rescue bisphosphonate treatment of alveolar bone improves extraction socket healing and reduces osteonecrosis in zoledronate-treated mice.
Hokugo A; Kanayama K; Sun S; Morinaga K; Sun Y; Wu Q; Sasaki H; Okawa H; Evans C; Ebetino FH; Lundy MW; Sadrerafi K; McKenna CE; Nishimura I
Bone; 2019 Jun; 123():115-128. PubMed ID: 30926440
[TBL] [Abstract][Full Text] [Related]
16. Does inflammatory dental disease affect the development of medication-related osteonecrosis of the jaw in patients using high-dose bone-modifying agents?
Ueda N; Nakashima C; Aoki K; Shimotsuji H; Nakaue K; Yoshioka H; Kurokawa S; Imai Y; Kirita T
Clin Oral Investig; 2021 May; 25(5):3087-3093. PubMed ID: 33057886
[TBL] [Abstract][Full Text] [Related]
17. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
[TBL] [Abstract][Full Text] [Related]
18. Multiple myeloma identified within the same site of the mandible with medication-related osteonecrosis of jaw: An unusual case report.
Wu XH; Chen SW
Medicine (Baltimore); 2023 Jul; 102(29):e34260. PubMed ID: 37478232
[TBL] [Abstract][Full Text] [Related]
19. Pre-existing medication-related osteonecrosis of the jaw before dental extraction.
Al-Sarraj M; Burns M; Patel V
Br Dent J; 2023 Nov; 235(10):783-788. PubMed ID: 38001199
[TBL] [Abstract][Full Text] [Related]
20. A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?
Hasegawa T; Kawakita A; Ueda N; Funahara R; Tachibana A; Kobayashi M; Kondou E; Takeda D; Kojima Y; Sato S; Yanamoto S; Komatsubara H; Umeda M; Kirita T; Kurita H; Shibuya Y; Komori T;
Osteoporos Int; 2017 Aug; 28(8):2465-2473. PubMed ID: 28451732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]